Concepedia

Timothy J. Hartingh

TJ

Statistics

Publications

6

Citations

204

H-Index

6

Active since

2008

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Merck Canada Inc. (Canada)

Timothy J. Hartingh is an author at United States Military Academy specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

2008–2024

6

Publications

6

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

Antonella Converso, Timothy J. Hartingh, R. M. Garbaccio et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 74 citations · Full text

, , +10

Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia

M. E. Layton, Jeffrey C. Kern, Timothy J. Hartingh et al. · Journal of Medicinal Chemistry · 2023 · 40 citations · Full text

, , +14

Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors

Izzat T. Raheem, Abbas M. Walji, Daniel J. Klein et al. · Journal of Medicinal Chemistry · 2015 · 36 citations

, , +17

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic

Valerie W. Shurtleff, M. E. Layton, Craig A. Parish et al. · Journal of Medicinal Chemistry · 2024 · 28 citations

, , +16

Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase

Antonella Converso, Timothy J. Hartingh, Mark E. Fraley et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 14 citations · Full text

, , +12

1–5 of 6